IHH Healthcare

The group monitors over 360 quality indicators across eight high-volume procedures.

The platform can analyse more than 250 biomarkers from a single blood sample.

Selected medical procedure packages will be offered.

The facility offers treatment for head and neck tumours, breast health, and more.

The laboratory is three times larger than its predecessor.

It will serve as the group’s 19th hospital in the country.

The facility was previously known as Ang Mo Kio FMC.

The new facility offers expanded access to diagnostic services.

Its Singapore operations are expected to soften in the same period.

The group plans to open an ambulatory care centre next year.

Excluding exceptional items, earnings grew by 35%. 

The group expects over $46m (RM200m) in synergies within five years.

Revenue for the period increased by 30%.

The centre features robotic automation, including scope delivery.

Hear from Sipika Singh, Chief Commercial Officer at IHH Healthcare Malaysia and Jennifer Soon, Chief Operating Officer at Prince Court Medical Centre as they discuss the winning initiatives that secured them four accolades at the Healthcare Asia Awards 2024.

The centre marks a significant advancement in cancer treatment technology in Singapore, offering precise radiation therapy with fewer side effects.